Gilead invites applications for its HIV or hepatitis C virus no co-infection programme – micro-elimination of HCV in HIV-infected and high-risk HIV-uninfected populations. This supports research focused on addressing the challenges associated with hepatitis C virus (HCV) elimination for individuals co-infected with HIV or in people at high risk for HIV infection.
Funding & Duration
Funding is worth up to USD $600,000 (approx AUD $808,000) per project for two to three years.
Academic institutions, community organisations, research networks and clinical investigators may apply.
Submission Requirements & Due Date
- 20 August 2018 – Letter of Intent submitted to Sponsor
- 9 November 2018 – full applications submitted for internal review
- Please email email@example.com if you are considering applying for this scheme.
- See also: Submitting an Application to Research Services for Review